[Drug therapy of intractable mycoses].
Ikemoto
H
H
D000284:Administration, Oral; D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D003453:Cryptococcosis / Q000188:drug therapy; D015725:Fluconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D005437:Flucytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D007262:Infusions, Intravenous; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008825:Miconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D009181:Mycoses / Q000188:drug therapy*
D008825:Miconazole; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine